Biotech Stocks Making Headlines - ADRX, CNSY, JAGX, AGL, ONCO

Biotech and healthcare stocks drew attention on Sept. 25, 2026 as multiple company developments and market moves surfaced. ADARx Pharmaceuticals priced an upsized initial public offering at $17.00 per share, selling 26.25 million shares for about $446.3 million in gross proceeds, with underwriters granted an option to buy up to 3.94 million more; shares were trading at $21.16, up 24.44%. Cerenome secured an in-network reimbursement agreement with Blue Cross Blue Shield of Michigan covering about 158 million lives, and scheduled a business update call for Sept. 30; CNSY was up 8.68% at $2.03. Jaguar Health completed a 1-for-15 reverse split and noted fee waivers tied to its portfolio, while agilon health expanded its Springfield Clinic partnership supporting about 21,000 additional Medicare beneficiaries.